Introducing Sesame’s New Clinical Weight Loss Program Featuring Novo Nordisk’s Wegovy
If you’ve been struggling to access weight loss and diabetes medications due to supply shortages or high costs, Sesame has some exciting news for you. The health-care marketplace has launched a new program that will allow eligible consumers to access compounded versions of Novo Nordisk’s blockbuster obesity drug Wegovy for just $249 per month.
Sesame is revolutionizing the way patients access healthcare by enabling them to book and pay for appointments with doctors and specialists directly through its platform, cutting out middlemen like insurers. In addition to offering branded weight loss and diabetes drugs through partnerships with companies like Costco, Sesame is now adding compounded semaglutide to its platform to provide users with affordable and accessible treatment options.
But what exactly are compounded medications, and how do they differ from branded drugs? Compounded medications are custom-made alternatives designed to meet a specific patient’s needs, such as allergies or difficulty swallowing pills. These medications are typically cheaper than their branded counterparts, making them a more affordable option for consumers.
“We are, based on this drug supply shortage, on behalf of American consumers, making a version of compounded semaglutide available to our users at a very accessible price point,” said Michael Botta, president and co-founder of Sesame. “In fact, we think it’s probably the most affordable price point the consumer can find on an apples to apples basis.”
Supply shortages are a major issue for pharmaceutical companies like Novo Nordisk and Eli Lilly, causing difficulties for patients trying to access vital medications. By offering compounded versions of popular weight loss and diabetes medications like Wegovy and Ozempic, Sesame is helping bridge the gap and provide patients with the treatments they need.
To participate in Sesame’s new program, patients will need to fill out an intake form, select a health-care provider, and have a consultation via video chat. They will also have access to ongoing consultations, a nutrition and fitness content library, and mindfulness resources. This comprehensive approach to weight loss and diabetes management sets Sesame apart from its competitors in the digital health space.
At Extreme Investor Network, we are committed to providing our readers with the latest news and insights in the world of business. Stay tuned for more updates on innovative companies like Sesame that are revolutionizing the healthcare industry and making a difference in the lives of consumers.